Biography
Bob Crabtree was educated at New College, Oxford with Malcolm Green, did his Ph.D. with Joseph Chatt at Sussex University and spent four years in Paris in Hugh Felkin's lab at the CNRS Natural Products Institute, headed at that time by Derek Barton. In 1977 he came to the US as an Assistant Professor at Yale, where he is now Whitehead Professor of Chemistry. He has been A.P. Sloan Foundation Fellow and Dreyfus Teacher-Scholar, received the ACS and Royal Soc. of Chem. Awards for organometallic chemistry and has been Chair of the Division of Inorganic Chemistry of ACS. He has also received the Mack (Ohio State), Karcher (Oklahoma), Job (Memorial U) and Kolosapoff (Auburn U, 2010) Awards, been an H.C. Brown Lecturer at Purdue University, Dow lecturer at Berkeley, Sabatier Lecturer at Toulouse, Williams Lecturer at Oxford, Osborn Lecturer at Strasbourg, Mond Lecturer (UK) and visiting Professor at the Universities of Paris, Toulouse and Montpellier.
Research Interest
Research Design and synthesis of inorganic, coordination or organometallic molecules with unusual structures and properties.
Biography
Craig L Hill trained at MIT (PhD; Whitesides) and Stanford (NSF PD; Holm) and is the Goodrich C. White Professor of Chemistry at Emory University. He studies catalysis (green oxidations; multielectron processes, decontamination, others), mechanisms and materials. He has trained ~130 graduate students and postdocs. Google Scholar lists ~340 journal publications that are cited 20,065 times (H index = 72). Three of these already exceed 1000 citations. He has been the recipient of three ACS awards, many others and is a member of two academies.
Research Interest
He studies catalysis (green oxidations; multielectron processes, decontamination, others), mechanisms and materials
Biography
John Littleton studied Pharmacology and Medicine as an MD PhD student at Kings College, London University in England. He continued academic research at Kings College, mostly in CNS target validation, as a Professor in the Pharmacology Department until 1993. At this time he spent a year at the University of Kentucky on a Wellcome Foundation fellowship where he started to develop an interest in novel technologies for plant drug discovery. He returned to Kentucky in 1995 to further develop the plant drug discovery aspect of his research, using novel methods of mutagenesis and high throughput screening in plant cell cultures. He co-founded the biotechnology company, Naprogenix Inc, in 2002 to commercialize these methods. With support from NIH (SBIR/STTR awards) and Kentucky (matching funds for these) Naprogenix and the University of Kentucky have refined the technology to its current state. The technology now utilizes the expression of protein targets in plant cells, followed by mutagenesis and selection for clones generating metabolites which interact with the target. Dr Littleton lives in downtown Lexington with his wife Susan Barron, who is a Professor in Psychology at the University, and his teenage daughter Elise.
Research Interest
The technology now utilizes the expression of protein targets in plant cells, followed by mutagenesis and selection for clones generating metabolites which interact with the target
